Company / Operating Cash Flow per Share
SOLENO THERAPEUTICS INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.89
FY2025
5-year range
-$5.22 / $0.89
FY2021-FY2025
Trend
+151.9%
vs FY2024
Sector context
#56 of 210
Health Care
What the data says
At $0.89, SOLENO THERAPEUTICS INC's operating cash flow per share ranks #56 of 210 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-5.22 in FY2021 to $0.89 in FY2025.
Based on SEC 10-K filings.
0.89 in FY2025.
Improved from $-1.51 to $0.89 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#56 of 210 in Health CareTop 27% of 210This company $0.89 Sector average $5.30
▼
-83.1% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 151.9% year-over-year.
- Ranks #56 out of 210 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.89 | +151.9% |
| FY2024 | -$1.72 | -13.7% |
| FY2023 | -$1.51 | +38.9% |
| FY2022 | -$2.47 | +52.6% |
| FY2021 | -$5.22 | -1196.4% |
| FY2020 | -$0.40 | +20.8% |
| FY2019 | -$0.51 | +8.6% |
| FY2018 | -$0.56 | +49.7% |
| FY2017 | -$1.11 | -15.1% |
| FY2016 | -$0.96 | +36.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026